Stay updated with breaking news from Indeterminate Response. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
In the Performance to Primary, Secondary and Tertiary Objectives second table the 90 day results were misstated and has been corrected in this press release.TORONTO, ON / ACCESSWIRE / May 30, 2023 / Theralase®
Theralase(R) Releases 1Q2023 Interim Financial Statements
TORONTO, ON / ACCESSWIRE / May 30 2023 / Theralase® Technologies Inc. ("Theralase" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development
Theralase(R) Releases Corrected and Restated Press Release for 1Q2023 ...
Theralase Provides Update on Phase II Bladder Cancer Study